BioCentury
ARTICLE | Company News

Acrongenomics, Molecular Vision deal

August 25, 2008 7:00 AM UTC

Acrongenomics returned exclusive rights to develop and commercialize Molecular Vision’s IP covering BioLED technology. In exchange, Acrongenomics will receive royalties on products that use the IP. Ac...